These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28579115)

  • 21. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
    Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
    JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of acquired von Willebrand syndrome during short-term micro axial pump support: implications for bleeding in a patient bridged to a long-term continuous-flow left ventricular assist device.
    Davis ME; Haglund NA; Tricarico NM; Keebler ME; Maltais S
    ASAIO J; 2014; 60(3):355-7. PubMed ID: 24614358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Von Willebrand factor, a versatile player in gastrointestinal bleeding in left ventricular assist device recipients?
    Fischer Q; Huisse MG; Voiriot G; Caron C; Lepage L; Dilly MP; Nataf P; Ajzenberg N; Kirsch M
    Transfusion; 2015 Jan; 55(1):51-4. PubMed ID: 25052086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation strategy in a patient on the HeartMate III® left ventricular assist device with acquired von Willebrand syndrome and recurring gastrointestinal bleeding episodes: sometimes less is more.
    Grabner B; Quehenberger P; Schaefer AK; Steinlechner B
    Eur J Cardiothorac Surg; 2020 Apr; 57(4):796-798. PubMed ID: 31177280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biological basis of thrombosis and bleeding in patients with ventricular assist devices.
    John R; Lee S
    J Cardiovasc Transl Res; 2009 Mar; 2(1):63-70. PubMed ID: 20559970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
    Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired von Willebrand syndrome associated with left ventricular assist device.
    Nascimbene A; Neelamegham S; Frazier OH; Moake JL; Dong JF
    Blood; 2016 Jun; 127(25):3133-41. PubMed ID: 27143258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management.
    Guha A; Eshelbrenner CL; Richards DM; Monsour HP
    Methodist Debakey Cardiovasc J; 2015; 11(1):24-7. PubMed ID: 25793026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors of Gastrointestinal Bleeding After Continuous Flow Left Ventricular Assist Device.
    Balcioglu O; Kemal HS; Ertugay S; Ozturk P; Engin Y; Nalbantgil S; Engin C; Yagdi T; Ozbaran M
    ASAIO J; 2018; 64(4):458-461. PubMed ID: 28957820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous-Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding.
    Kim JH; Brophy DF; Shah KB
    Cardiol Clin; 2018 Nov; 36(4):519-529. PubMed ID: 30297069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implication of Hemodynamic Assessment during Durable Left Ventricular Assist Device Support.
    Imamura T; Narang N
    Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32824131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal Angiodysplasia.
    Kang J; Hennessy-Strahs S; Kwiatkowski P; Bermudez CA; Acker MA; Atluri P; McConnell PI; Bartoli CR
    Circ Res; 2017 Sep; 121(8):963-969. PubMed ID: 28729354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parameters.
    Bartoli CR; Ghotra AS; Pachika AR; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2014 Aug; 62(5):414-8. PubMed ID: 24995532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.
    Restle DJ; Zhang DM; Hung G; Howard JL; Kallel F; Acker MA; Atluri P; Bartoli CR
    Artif Organs; 2015 Jul; 39(7):569-75. PubMed ID: 25810063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are elevated serum haemolysis markers a harbinger of adverse events in HeartMate II patients?
    Zayat R; Shoaib M; Khattab MA; Ahmad U; Goetzenich A; Stoppe C; Foldenauer AC; Moza A; Schnoering H; Autschbach R; Tewarie L
    Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):5-12. PubMed ID: 29444250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
    Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A single-centre experience.
    Litzler PY; Smail H; Barbay V; Nafeh-Bizet C; Bouchart F; Baste JM; Abriou C; Bessou JP
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):55-9; discussion 59-60. PubMed ID: 23671203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
    Meyer AL; Malehsa D; Bara C; Budde U; Slaughter MS; Haverich A; Strueber M
    Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.